Status:
COMPLETED
State Dependence of Prefrontal Transcranial Magnetic Stimulation
Lead Sponsor:
University of Minnesota
Conditions:
Healthy
Eligibility:
All Genders
18-65 years
Phase:
PHASE4
Brief Summary
The study will examine whether the benefits of brain stimulation on mental functioning can be enhanced if an individual is actively engaging the target brain networks while receiving brain stimulation...
Eligibility Criteria
Inclusion
- Age 18 - 65,
- healthy controls
Exclusion
- Diagnosed psychiatric disorder
- Potential contraindications to EEG (e.g. visible scalp abrasions, non-removable hair extensions and/or hair styling that would impede proper EEG recording)
- Potential contraindication to TMS (as identified by the TMS safety screener)
- Any previous adverse reaction to TMS or MRI
- Diagnosed epilepsy or previously experienced a seizure
- Diagnosed neurological condition, such as stroke or tinnitus
- Experienced a head trauma that was diagnosed as concussion
- Current use of, or recent withdrawal from, medications that can increase the risk of seizure
- Currently pregnant
- Any metal in the head (excluding mouth)
- Any implanted medical device
Key Trial Info
Start Date :
August 24 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 17 2025
Estimated Enrollment :
51 Patients enrolled
Trial Details
Trial ID
NCT05962385
Start Date
August 24 2023
End Date
November 17 2025
Last Update
December 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Minnesota
Minneapolis, Minnesota, United States, 55455